Clinical Trial Update: Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers. [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study assessed interactions between EDP-305 and midazolam, caffeine, and rosuvastatin in healthy volunteers; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• Caffeine (caffeine)
• EDP-305
• Midazolam (Midazolam)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Enanta Pharmaceuticals, Inc | Conditions: NASH | Phase 1 | Status: COMPLETED